Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    26-July-2000      
Issue 104 Next Update - 14:00 UTC 08:00 EST    27-July-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Imaging And Alcoholism:

A Window On The Brain

The processes that initiate and maintain alcoholism are regulated by interactions among nerve cells (i.e., neurons) in the brain. These mechanisms interact with emotional, cognitive, and social factors to determine an individual’s response to alcohol consumption. Imaging techniques1 allow scientists to study the link between brain and behavior with minimal risk to the patient. Using imaging, scientists can watch the brain in action as a person performs intellectual tasks, reacts to the environment, or experiences emotions. Data obtained before, during, and after a person has consumed alcohol can be compared and analyzed. Imaging offers the promise of integrating biomedical, psychosocial, and behavioral aspects of alcoholism, leading to improved prevention and treatment. This Vidyya article illustrates some current and potential applications of imaging to alcoholism research. The information is from the National Institute on Alcohol Abuse and Alcoholism.

Alcohol’s Effects on Brain Structure and Function

Results of autopsy studies show that patients with a history of chronic alcohol consumption have smaller, lighter, more shrunken brains than nonalcoholic adults of the same age and gender (1). This finding has been repeatedly confirmed in living alcoholics using structural imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI). Structural imaging reveals a consistent association between heavy drinking and physical brain damage, even in the absence of medical conditions previously considered to be clinical indicators of severe alcoholism (e.g., chronic liver disease or alcohol-induced dementia).

Imaging reveals shrinkage to be more extensive in the folded outer layer (i.e., cortex) of the frontal lobe (2), which is believed to be the seat of higher intellectual functions. In men, vulnerability to frontal lobe shrinkage increases with age (2-4). Current studies will determine if the same effect occurs in women. Repeated imaging of a group of alcoholics who continued drinking over a 5-year period showed progressive brain shrinkage that significantly exceeded normal age-related shrinkage (5). The rate of frontal cortex shrinkage in this study correlated approximately with the amount of alcohol consumed (5).

Shrinkage also occurs in deeper brain regions, including brain structures associated with memory (6-8), as well as in the cerebellum, which helps regulate coordination and balance (9). Limited research suggests that women may be more susceptible than men to alcohol-related brain shrinkage (10,11).

The detection of structural brain damage is complemented by results of functional imaging techniques, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT). By measuring local changes in blood flow and energy metabolism, PET and SPECT can help identify brain regions involved in specific sensory, motor, or cognitive functions. Such studies consistently reveal decreased blood flow and metabolic rates in certain brain regions of heavy drinkers compared with those of nonalcoholics (12,13), even in the absence of measurable shrinkage (14). Structural and functional defects revealed by magnetic resonance spectroscopy (MRS) and PET may reflect a decrease in the number (15) or size (16,17) of neurons or a reduction in the density of communication sites between adjacent neurons (16,17).

Relating Structure and Function to Behavior

A key goal of imaging in alcoholism research is to detect changes in specific brain regions that can be correlated with alcohol-related behaviors. Imaging of the cerebellum has linked both shrinkage (9,18) and decreased blood flow (19) to impaired balance and gait. Such impairment may cause falls among older alcoholics, leading to head injury that may exacerbate brain dysfunction. Studies of cognitive performance, however, have found no consistent relationship between shrinkage of the frontal cortex and impairment of short-term memory and problem-solving (1,20), functions typically disrupted by frontal lobe damage. Conversely, some studies have found an approximate correlation between shrinkage of memory-related brain structures (e.g., mammillary bodies) and the degree of memory impairment (7). Functional imaging studies show that frontal lobe blood flow (21) and metabolism (12) may decrease in alcoholics before significant shrinkage or major cognitive problems become detectable (13,21).

Cognitive functions and motor coordination may improve at least partially within 3 to 4 weeks of abstinence (20) accompanied by at least partial reversal of brain shrinkage (22,23) and some recovery of metabolic functions in the frontal lobes (24) and cerebellum (17,25). Frontal lobe blood flow continues to increase with abstinence, returning to approximately normal levels within 4 years (26). Relapse to drinking leads to resumption of shrinkage (23), continued declines in metabolism and cognitive function (24), and evidence of neuronal cell damage (25).

Mechanisms of Addiction

Studies using animals or cultured slices of brain tissue have identified chemical messengers (i.e., neurotransmitters) and neuronal pathways that may help mediate alcohol’s effects. Functional imaging studies are confirming and extending these results. For example, a neuronal pathway involving the neurotransmitter dopamine has been implicated in the development of alcoholism. Nonalcoholic social drinkers administered a mildly intoxicating dose of alcohol (19) and alcoholic subjects experiencing craving for alcohol (27) exhibit decreased blood flow in parts of the brain where dopamine is present. Imaging studies also provide evidence for disrupted response of the neurotransmitter serotonin, which appears to interact with dopamine in the development of alcoholism (28).

Functional imaging reveals that alcoholics have diminished metabolic activity in several frontal brain regions early and late in withdrawal (29,30). In nonalcoholics, benzodiazepine sedatives, some of which are commonly used to treat alcohol withdrawal, produce a temporary alcohol-like impairment of coordination and cognition accompanied by an overall decrease in the brain’s metabolic rate. In alcoholics, some frontal brain regions exhibit a smaller metabolic change following benzodiazepine administration than is seen in nonalcoholics. These results may indicate a diminished capacity for dampening excessive neuronal activity, possibly weakening a person’s ability to inhibit behavior (30). Among nonalcoholic social drinkers, the effects of benzodiazepines on specific brain regions as assessed by PET (31) and functional MRI (32) differ between persons with and without a family history of alcoholism. Therefore, an abnormal reaction to benzodiazepines may represent a preexisting risk factor for alcoholism rather than a consequence of long-term alcohol consumption.

A promising application of functional imaging is in the study of cognitive and emotional processes involved in addiction, craving, and relapse. For example, preliminary studies have correlated craving for cocaine with increased metabolism in a neuronal network that integrates emotional and cognitive aspects of memory (33). Similar mechanisms implicated in craving for alcohol may help account for individual differences in vulnerability to alcoholism (34).

Treatment of Alcoholism

Diagnosis. Routine clinical applications of imaging include detecting conditions that commonly co-occur with alcoholism, such as residual brain damage from head trauma (35), various psychiatric disorders (36), and alcohol-induced organic brain disorders characterized by dementia or amnesia (37).

Withdrawal. Up to 15 percent of alcoholics experience seizures during withdrawal, and the likelihood of having such seizures, as well as their severity, increases with the number of past withdrawal episodes. In a structural imaging study of alcoholics who had undergone seizures, Sullivan and colleagues (38) found shrinkage on both sides of the brain behind the frontal lobes. It is not known whether seizures cause the shrinkage or result, in part, from preexisting damage to the area.

Investigators have used PET and SPECT to locate and quantify sites on neuronal surfaces where neurotransmitters implicated in the development of alcoholism interact with the neuron. Results of such research has implicated impaired serotonin function in the severe depression that often accompanies withdrawal (39). Functional imaging is also being used to help evaluate the effects of naloxone on withdrawal-induced craving (40). This medication is chemically related to the anticraving medication naltrexone (ReVia(TM)).

Psychosocial Therapies. Higgins (41) describes the concept of neurobehavioral treatment, which emphasizes learning-based approaches to relapse prevention while paying special attention to the neurobiologic changes that accompany abstinence. For example, a common treatment strategy involves the development of skills for recognizing and coping with environmental influences or emotional states that may induce craving and trigger drinking. This approach requires the ability to monitor and evaluate one’s behavior and learn from failed efforts (41). Researchers are using functional imaging to investigate the basis for impairment of these cognitive functions (42).

Appendix: Imaging Techniques

Structural imaging depicts a three-dimensional "slice" of the brain, showing more detail than a conventional X ray. CT is a refinement of x-ray technology, whereas MRI interprets signals emitted by the brain in the presence of a strong magnetic field (43). These techniques are commonly used to help diagnose certain medical conditions (e.g., tumors) as well as in research.

Functional imaging techniques in common use include PET, SPECT, and modifications of magnetic resonance technology (14,43). PET and SPECT provide computer-generated, color-coded, three-dimensional images of the distribution within the brain of radioactive substances injected into the bloodstream. These images can be used to detect changes in blood flow in specific brain regions or to determine the locations of various neurotransmitters or receptors. Functional MRI can locate and assess levels of brain activation associated with motor, sensory, or cognitive processes that may be impaired by alcohol over time at intervals as short as a few seconds (44). MRS can detect specific molecules, including alcohol itself (45), and can detect metabolic changes underlying deterioration of neuronal structural integrity (43).


Imaging and Alcoholism: A Window on the Brain—A Commentary by NIAAA Director Enoch Gordis, M.D.

Imaging technology has helped alcohol researchers to study how alcohol damages internal organs, such as the brain and the liver. More recent advances in imaging techniques are allowing investigators to also study alcohol dependence itself. Scientists are beginning to measure alcohol’s effects on mood, emotional states, craving, and cognition while simultaneously assessing metabolic, physiologic, and neurochemical function in the brain. These innovations in imaging technology will help not only the alcohol field, but also all fields of medicine where biology and behavior are so closely linked.


References


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.